Pcn3 - Real World Evidence of Metastatic Breast Cancer Treatment: A Comparison of Adverse Effects Between Palbociclib Treatment and Endocrine Therapy

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.086
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Palbociclib in Metastatic Breast Cancer: Current Evidence and Real-Life Data

Drugs in Context
Molecular MedicinePharmacology
2019English

Real-World Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis

Scientific Reports
Multidisciplinary
2019English

Palbociclib: An Evidence-Based Review of Its Potential in the Treatment of Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2014English

Palbociclib in Combination With Hormone Therapy for Luminal Her2-Negative Metastatic Breast Cancer: New Highly Effective Strategy of Drug Treatment

Tumors of female reproductive system
2017English

Real‐world Treatment Patterns and Outcomes in Refractory Metastatic Colorectal Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Risk Factors Affecting Adverse Effects of Cyclosporine a in a Real-World Psoriasis Treatment

Annals of Dermatology
Dermatology
2018English

Adverse Effects of Adjuvant Endocrine Therapy

Medical Council
2018English

Vectors for Treatment of Metastatic Breast Cancer

2005English

Trastuzumab in the Treatment of Metastatic Breast Cancer : Anticancer Therapy Versus Cardiotoxicity

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy